Skip to main content
Clinical Trials/IRCT20221219056864N1
IRCT20221219056864N1RecruitingPhase 3

Investigation The effect of alpha-lipoid acid on saliva rate of the patients underwent radiotherapy of head and neck cancers

Shahid Beheshti University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients with head and neck cancers with a total radiation dose of 56-70 Gy

Exclusion Criteria

  • History of liver disease, diabetes, thyroid
  • History of alcohol consumption
  • Malnutrition
  • Receiving any chemotherapy drugs
  • History of salivary gland cancer
  • History of treatment with alpha-lipoid acid for any other reason
  • History of allergy to alpha-lipoid acid or other antioxidants and food supplements
  • Consumption of iron products
  • Pregnant or lactating women

Investigators

Similar Trials